Emergence of resistance to imipenem in Pseudomonas aeruginosa.
about
Biochemical and Structural Characterization of Mycobacterium tuberculosis β-Lactamase with the Carbapenems Ertapenem and DoripenemProtein D2 porin of the Pseudomonas aeruginosa outer membrane bears the protease activityAssociation of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem.Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins.Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acidsC-terminal region of Pseudomonas aeruginosa outer membrane porin OprD modulates susceptibility to meropenem.The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibilityAntibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.Activity of carbapenem BMS-181139 against Pseudomonas aeruginosa is not dependent on porin protein D2.Role of mutations in DNA gyrase genes in ciprofloxacin resistance of Pseudomonas aeruginosa susceptible or resistant to imipenem.Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosaDecreased outer membrane permeability in imipenem-resistant mutants of Pseudomonas aeruginosaOuter membrane barrier as a mechanism of antimicrobial resistance.Pharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro model.Addition of rifampin to combination antibiotic therapy for Pseudomonas aeruginosa bacteremia: prospective trial using the Zelen protocol.Role of the Outer Membrane Protein OprD2 in Carbapenem-Resistance Mechanisms of Pseudomonas aeruginosaCharacterization of a Carbapenem-Hydrolyzing Enzyme, PoxB, in Pseudomonas aeruginosa PAO1.Resistance to pefloxacin in Pseudomonas aeruginosa.Pseudoresistance of Pseudomonas aeruginosa resulting from degradation of imipenem in an automated susceptibility testing system with predried panels.Structure and function of OprD protein in Pseudomonas aeruginosa: from antibiotic resistance to novel therapies.The use of carbapenems in the treatment of serious infections.Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance.Role of putative loops 2 and 3 in imipenem passage through the specific porin OprD of Pseudomonas aeruginosa.Diffusion of beta-lactam antibiotics through liposome membranes reconstituted from purified porins of the outer membrane of Pseudomonas aeruginosa.New norfloxacin resistance gene in Pseudomonas aeruginosa PAO.Selective imipenem resistance in Pseudomonas aeruginosa associated with diminished outer membrane permeability.Susceptibility of Pseudomonas species to the novel antibiotics mureidomycinsIn vitro activity of E1040 against imipenem-resistant Pseudomonas aeruginosa strains.Transient carbapenem resistance induced by salicylate in Pseudomonas aeruginosa associated with suppression of outer membrane protein D2 synthesis.Genetic definition of the substrate selectivity of outer membrane porin protein OprD of Pseudomonas aeruginosaRole of protein F in maintaining structural integrity of the Pseudomonas aeruginosa outer membrane.Transferable imipenem resistance in Pseudomonas aeruginosa.Imipenem resistance in pseudomonas aeruginosa PAO: mapping of the OprD2 gene.Role of membrane permeability in determining antibiotic resistance in Pseudomonas aeruginosa.Mechanism of imipenem resistance acquired by three Pseudomonas aeruginosa strains during imipenem therapy.Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates.Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance.An important role of a "probable ATP-binding component of ABC transporter" during the process of Pseudomonas aeruginosa resistance to fluoroquinolone.In-vitro activity of ciprofloxacin and other beta-lactam antibiotics against gentamicin- and carbenicillin-resistant isolates of Pseudomonas aeruginosa.In-vitro susceptibility of clinical isolates of Pseudomonas aeruginosa to beta-lactam and aminoglycoside antibiotics.
P2860
Q27660367-1C80DCC6-70BC-4DA5-AAE2-36D8032F193BQ28492681-E4D807D6-3831-4B54-B168-0A46BD8ABE26Q33743757-7D57CB33-E49A-4005-B746-C71B443EEAF0Q33744061-7163429A-4ABA-4C41-A6EC-C69B71517BB2Q33976208-3DBA2C81-45E6-4055-92EA-D6D59F938CAEQ33982298-A28F001B-C915-48B8-9E32-3B5162F93968Q34922676-5E8AD563-C3F6-4B9D-A577-48AC23696621Q35007624-800FD895-1D3D-490B-96F3-E228B94C7335Q35111583-E875F759-3CA6-47BF-9D03-78D85D6B45A7Q35119495-C2A9D853-A464-47A4-A5BA-19D1AB69A53BQ35245618-091EB95A-1D6B-4F52-821C-61CEB7E6716FQ35341336-DAF53349-F2E6-43B5-90A4-ADA43D3626EAQ35357625-D44145E9-6598-4D0F-B856-2569320C9F0EQ35819487-79AD2EBE-7E31-425D-BAE8-551C5CEBF87BQ35867214-E2883317-638B-4270-84AB-39047BBDA712Q36126904-3895C864-17C2-4A79-89A9-5C3E5F6DF2E1Q36571851-EF263ED9-61B9-4E77-B68C-E4F57C880CBDQ36753117-1B6F34DF-84DF-481C-A7A4-B77F0AC5AA8DQ37230830-333A8497-7E55-4728-B466-2A06F37C533CQ37317645-0EFEF788-310E-4C1B-8863-95C892F41084Q37555757-8DC4A429-1DC7-4B0A-89E1-10FE4297AC13Q38049220-8CDCED2A-2D5D-4CDB-B016-0D9685F9D325Q39474511-5287FFF1-0146-4A09-A0D5-8AEF72F28ECCQ39815788-79C22213-5858-4D6A-8686-17160F29A0BCQ39816779-033F8C1D-9BAB-4687-A0D8-7E8ADCB7CADAQ39818721-B1B5A124-5450-49D4-9F68-85D1904CA882Q39869377-B0C20FDA-DB65-4086-82CD-3931E4E7BBA7Q39875919-6979E2A5-B111-46A2-83B4-679B330B4C71Q39883838-250EF9A4-4EF9-4188-8DA0-790915EA00CFQ39938084-62223A3B-C42E-4C67-8DBA-0596E9DDAA42Q39947995-1DDAD71F-95FE-491B-B264-F9365E3EE557Q40085630-35100578-FEDB-4F8F-AB5E-104F9C753014Q40086366-A018CCBD-219C-4112-B49F-D2A0E7CDDDEBQ40403515-54256A66-1959-4A80-BB4B-E0C9D95368A3Q43806135-40DF8FF0-53FA-48EC-9C00-CF8143B95387Q44282478-8C7EDD7C-23AC-4126-A68E-2E6E09494B8AQ44948525-E681DC08-CFD0-44B2-AED6-6F1881DD75E1Q46982111-9E4EDA4D-FEAC-4148-9C70-544149A2F778Q54302894-DF0D56B7-6BDA-45B7-85F1-C2AE13AA505DQ54340360-84695788-63BC-447C-8ABF-4D7913337B10
P2860
Emergence of resistance to imipenem in Pseudomonas aeruginosa.
description
1987 nî lūn-bûn
@nan
1987 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Emergence of resistance to imipenem in Pseudomonas aeruginosa.
@ast
Emergence of resistance to imipenem in Pseudomonas aeruginosa.
@en
type
label
Emergence of resistance to imipenem in Pseudomonas aeruginosa.
@ast
Emergence of resistance to imipenem in Pseudomonas aeruginosa.
@en
prefLabel
Emergence of resistance to imipenem in Pseudomonas aeruginosa.
@ast
Emergence of resistance to imipenem in Pseudomonas aeruginosa.
@en
P2093
P2860
P356
P1476
Emergence of resistance to imipenem in Pseudomonas aeruginosa.
@en
P2093
P2860
P304
P356
10.1128/AAC.31.12.1892
P407
P577
1987-12-01T00:00:00Z